An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Transcat, Inc. will release its second quarter fiscal year 2024 results on October 30, 2023. The company will host a conference call and webcast to discuss the financial and operating results, corporate strategy, and outlook.
Positive
Transcat, Inc. will release its second quarter fiscal year 2024 results on October 30, 2023.
Negative
None.
ROCHESTER, N.Y.--(BUSINESS WIRE)--
Transcat, Inc. (Nasdaq: TRNS) (“Transcat” or the “Company”), a leading provider of accredited calibration services, enterprise asset management services, and value-added distributor of professional grade handheld test, measurement and control instrumentation, announced that it will release its second quarter fiscal year 2024 results after the close of financial markets on Monday, October 30, 2023.
The Company will host a conference call and webcast to review the financial and operating results for the period and discuss its corporate strategy and outlook. A question-and-answer session will follow.
Second Quarter Fiscal Year 2024 Conference Call
Tuesday, October 31, 2023
11:00 a.m. Eastern Time
Phone: (201) 689-8471
Webcast and accompanying slide presentation: https://www.transcat.com/investor-relations
A telephonic replay will be available from 2:00 p.m. ET on the day of the teleconference call until Tuesday, November 7, 2023. To listen to the archived call, dial (412) 317-6671 and enter conference ID number 13742041 or access the webcast replay at https://www.transcat.com/investor-relations, where a transcript will be posted once available.
ABOUT TRANSCAT
Transcat, Inc. is a leading provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, Computerized Maintenance Management System (CMMS), and pipette services. The Company is focused on providing best-in-class services and products to highly regulated industries, particularly the Life Science industry, which includes pharmaceutical, biotechnology, medical device, and other FDA-regulated businesses, as well as aerospace and defense, and energy and utilities. Transcat provides periodic on-site services, mobile calibration services, pickup and delivery, in-house services at its 28 Calibration Service Centers strategically located across the United States, Puerto Rico, Canada, and Ireland. The breadth and depth of measurement parameters addressed by Transcat’s ISO/IEC 17025 scopes of accreditation are believed to be the best in the industry.
Transcat also operates as a leading value-added distributor that markets, sells and rents new and used national and proprietary brand instruments to customers primarily in North America. The Company believes its combined Service and Distribution segment offerings, experience, technical expertise, and integrity create a unique and compelling value proposition for its customers.
Transcat’s strategy is to leverage its strong brand and unique value proposition that includes its comprehensive instrument service capabilities, enterprise asset management, and leading distribution platform to drive organic sales growth. The Company will also look to expand its addressable calibration market through acquisitions and capability investments to further realize the inherent leverage of its business model. More information about Transcat can be found at: Transcat.com.
about transcat transcat, inc. is a leading provider of accredited calibration, repair, inspection and compliance services including analytical instrument qualifications, equipment and process validation. targeted industries include life science, biotechnology, medical device, pharmaceutical and other fda-regulated industries, industrial manufacturing, energy and utilities, chemical manufacturing and other industries. throughout its 20 strategically located centers of excellence in the united states, canada and puerto rico, transcat delivers precise services with reliable turn-around times. the breadth and depth of measurement parameters addressed by transcat’s iso/iec 17025 scopes of accreditation are believed to be among the best in the industry. in addition, transcat operates as a leading distributor of professional grade handheld test, measurement and control instrumentation. through its distribution products segment, transcat markets and distributes premier and propriety brand inst